Apnimed, Inc.
APMD
IPO
$25.69
-$2.25-8.05%
NASDAQ
Corporate Info
Website
Phone Number
(617) 500-8880
Address
39 John F. Kennedy Street
4th Floor
Cambridge, MA 02138
4th Floor
Cambridge, MA 02138
Country
United States
Year Founded
2017
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
65
Business Description
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.